How Is Prenatal Screening Done?
Learn how prenatal screening is done in the US. Understand NIPT, carrier screening, and ultrasound. Order a comprehensive panel online today.
Prenatal screening is done through a combination of blood tests, ultrasound imaging, and sometimes genetic analysis to assess the risk of certain chromosomal conditions, genetic disorders, and anatomical abnormalities in a developing baby. In 2026, the standard approach in the United States typically begins with non-invasive prenatal testing (NIPT), which analyzes cell-free DNA from the mother's blood, followed by carrier screening for recessive conditions, and may include first-trimester screening or the quad screen later in pregnancy. These methods help expectant parents and healthcare providers make informed decisions about further diagnostic steps, such as chorionic villus sampling or amniocentesis, if needed.
What Is Non-Invasive Prenatal Testing (NIPT)?
NIPT, also called cell-free DNA screening, is the most common first-line screening test offered in the US as of 2026. It requires a simple blood draw from the mother, usually after 10 weeks of pregnancy. The laboratory isolates and analyzes fragments of fetal DNA circulating in the maternal bloodstream—known as the fetal fraction—to detect an increased risk for trisomies 21 (Down syndrome), 18 (Edwards syndrome), and 13 (Patau syndrome), as well as sex chromosome aneuploidies. NIPT has a high detection rate and low false-positive rate for these conditions, but it is a screening test, not a diagnosis.
How the NIPT Blood Draw Works
- A healthcare provider draws about 10–20 mL of blood from the mother's arm.
- The sample is sent to a certified genetic testing laboratory.
- Results are typically available within 7–10 business days.
- A fetal fraction of at least 4% is generally required for accurate analysis; if it is too low, the test may be repeated or an alternative screening method recommended.
Carrier Screening: What It Is and When It Is Done
Carrier screening is a separate type of prenatal screening that looks for recessive genetic mutations a parent may carry—such as those for cystic fibrosis, spinal muscular atrophy, or fragile X syndrome. It can be performed before pregnancy or during the first trimester. In the US, professional guidelines recommend offering carrier screening for all pregnant individuals, regardless of family history. Results help determine if both partners are carriers for the same condition, which would confer a 25% risk of the child being affected.
Comparison of Common Prenatal Screening Types
| Screening Type | Timing | What It Detects | Sample Required |
|---|---|---|---|
| NIPT (cell-free DNA) | From 10 weeks | Trisomies 21, 18, 13; sex chromosome aneuploidies | Maternal blood |
| First-trimester screening | 11–14 weeks | Risk for Down syndrome, trisomy 18; nuchal translucency | Blood + ultrasound |
| Quad screen (second-trimester) | 15–22 weeks | Risk for Down syndrome, trisomy 18, neural tube defects | Maternal blood |
| Carrier screening | Before or during pregnancy | Recessive genetic disorders (e.g., CF, SMA, fragile X) | Blood or saliva |
| Integrated screening | First + second trimester | Combined risk assessment for Down syndrome and trisomy 18 | Blood + ultrasound (two steps) |
What Are Chorionic Villus Sampling (CVS) and Amniocentesis?
CVS and amniocentesis are diagnostic procedures, not screening tests. They are offered after a positive screening result to confirm a diagnosis. CVS is performed between 10 and 13 weeks by taking a small sample of placental tissue. Amniocentesis is done between 15 and 20 weeks by withdrawing amniotic fluid. Both carry a small risk of miscarriage—typically cited as about 1 in 300 to 1 in 500 for CVS and 1 in 500 to 1 in 1,000 for amniocentesis in experienced centers. A genetic counselor can help interpret results and discuss options.
How to Choose the Right Screening Path
Your obstetrician or midwife will guide you based on your age, medical history, and preferences. Many US providers now offer NIPT as the primary screening for all pregnancies, with carrier screening as an optional add-on. Some patients opt for integrated screening, which combines first-trimester blood work and ultrasound with the quad screen for a more comprehensive risk assessment. A prenatal paternity test is also available through some labs, but it is separate from standard prenatal screening panels.
Important Medical Disclaimer
This guide is for educational purposes only and does not replace personalized medical advice. Prenatal screening results indicate risk, not certainty. Always discuss your results with a qualified healthcare provider or genetic counselor before making decisions about diagnostic testing or pregnancy management.
If you are ready to take the next step, you can order a prenatal screening panel online and receive your results quickly, with secure digital access and support from our team.
Ready to get screened? Order a prenatal carrier screening panel online through our partner and visit a local lab near you.
Order Prenatal Carrier ScreeningAbout PrenatalScreenings
PrenatalScreenings.com is a local lab information directory. We do not provide medical advice, diagnose conditions, or interpret test results. Always consult a qualified healthcare provider for personal medical guidance.